IRIS
DE MICCO, ROSA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.444
AS - Asia 2.105
NA - Nord America 1.673
SA - Sud America 310
Continente sconosciuto - Info sul continente non disponibili 143
AF - Africa 37
OC - Oceania 1
Totale 8.713
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 3.294
US - Stati Uniti d'America 1.620
SG - Singapore 749
CN - Cina 441
IE - Irlanda 340
IT - Italia 338
HK - Hong Kong 285
VN - Vietnam 274
BR - Brasile 264
DE - Germania 117
KR - Corea 116
GB - Regno Unito 101
JP - Giappone 81
FR - Francia 59
IN - India 54
UA - Ucraina 44
CA - Canada 28
SE - Svezia 28
TR - Turchia 28
FI - Finlandia 24
GR - Grecia 23
AR - Argentina 18
MX - Messico 17
NL - Olanda 15
AT - Austria 14
ZA - Sudafrica 14
PL - Polonia 12
CZ - Repubblica Ceca 11
ID - Indonesia 10
BD - Bangladesh 9
CO - Colombia 9
IQ - Iraq 9
UZ - Uzbekistan 9
MA - Marocco 8
JO - Giordania 7
PK - Pakistan 7
EC - Ecuador 5
ES - Italia 5
RO - Romania 5
BE - Belgio 4
KE - Kenya 4
PE - Perù 4
PH - Filippine 4
AZ - Azerbaigian 3
EG - Egitto 3
KZ - Kazakistan 3
LT - Lituania 3
TN - Tunisia 3
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
EE - Estonia 2
IL - Israele 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
NP - Nepal 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AG - Antigua e Barbuda 1
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
BO - Bolivia 1
BS - Bahamas 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KW - Kuwait 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PT - Portogallo 1
TM - Turkmenistan 1
TW - Taiwan 1
Totale 8.571
Salva come PNG Salva come JPEG
Città #
Moscow 1.195
Singapore 388
Dublin 340
San Jose 322
Santa Clara 295
Hong Kong 281
Ashburn 133
Seoul 115
Hefei 98
Ho Chi Minh City 87
Naples 78
Jacksonville 76
New York 72
Hanoi 64
Beijing 57
Chandler 56
Bengaluru 44
Princeton 34
Los Angeles 33
Bremen 32
Roxbury 32
Munich 30
The Dalles 26
São Paulo 25
Medford 23
Dallas 19
Napoli 18
Da Nang 17
London 16
Caserta 14
Orem 13
Rome 13
Boardman 12
Cambridge 12
Haiphong 12
Wilmington 12
Helsinki 11
Warsaw 11
Avella 10
Falkenstein 10
Frankfurt am Main 10
Istanbul 10
Nuremberg 10
Reggio Emilia 10
Brno 9
Des Moines 9
Memphis 9
Phoenix 9
Tashkent 9
Amsterdam 8
Aversa 8
Milan 8
Montreal 8
Amman 7
Ann Arbor 7
Council Bluffs 7
Curitiba 7
Jinan 7
Johannesburg 7
Manchester 7
Mexico City 7
Nanjing 7
Norwalk 7
Biên Hòa 6
Hải Dương 6
Ninh Bình 6
Rio de Janeiro 6
San Francisco 6
Shanghai 6
Stockholm 6
Thái Bình 6
Tokyo 6
Turku 6
Vienna 6
Viterbo 6
Buffalo 5
Casoria 5
Catania 5
Hangzhou 5
Quận Ba 5
Trento 5
Woodbridge 5
Zhengzhou 5
Belo Horizonte 4
Bogotá 4
Boston 4
Brooklyn 4
Cape Town 4
Casablanca 4
Chennai 4
Ercolano 4
Ha Long 4
Hillsboro 4
Houston 4
Lima 4
Nairobi 4
Nha Trang 4
Ningbo 4
Porto Alegre 4
Sacramento 4
Totale 4.503
Salva come PNG Salva come JPEG
Nome #
A transient third cranial nerve palsy as presenting sign of spontaneous intracranial hypotension 185
Cognitive impairment is associated with Hoehn and Yahr stages in early, de novo Parkinson disease patients 181
Clinical correlations of microstructural changes in progressive supranuclear palsy 168
Cognitive and morphometric features of mild cognitive impairment reversion in early patients with Parkinson's disease 155
Advanced visual network and cerebellar hyperresponsiveness to trigeminal nociception in migraine with aura 155
Medical retrofitting design 151
Cognitive Networks Disarrangement in Patients With Migraine Predicts Cutaneous Allodynia 150
Resting-state network connectivity changes in drug-naive Parkinson's disease patients with probable REM sleep behavior disorder 147
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders 146
Central pain processing in "drug-naïve" pain-free patients with Parkinson's disease 144
Arterial spin labeling MRI applied to migraine: current insights and future perspectives 142
Non-motor impairments affect walking kinematics in Parkinson disease patients: A cross-sectional study 140
Altered domain-specific striatal functional connectivity in patients with Parkinson's disease and urinary symptoms 136
Rhythm-specific modulation of the sensorimotor network in drug-naive patients with Parkinson's disease by levodopa. 136
Fatigue in Parkinson's disease: Italian validation of the Parkinson Fatigue Scale and the Fatigue Severity Scale using a Rasch analysis approach 136
Continuous intra jejunal infusion of levodopa-carbidopa intestinal gel by jejunal extension tube placement through percutaneous endoscopic gastrostomy for patients with advanced Parkinson's disease: a preliminary study 131
Olfactory loss and brain connectivity after COVID-19 127
Validation of the Italian version of carers’ quality-of-life questionnaire for parkinsonism (PQoL Carer) in progressive supranuclear palsy 126
Olfactory Loss and Brain Connectivity after COVID-19: Structural Follow-Up at One Year 123
A Bayesian approach to Essential Tremor plus: A preliminary analysis of the TITAN cohort 123
Connectivity Correlates of Anxiety Symptoms in Drug-Naive Parkinson's Disease Patients 120
Fatigue in Parkinson's disease: A systematic review and meta-analysis 119
Effectiveness and safety of an atropine/midazolam and target controlled infusion propofol-based moderate sedation protocol during percutaneous endoscopic transgastric jejunostomy procedures in Parkinson’s disease: a real-life retrospective observational study 117
Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease 117
Functional connectivity underpinnings of fatigue in "Drug-Naïve" patients with Parkinson's disease 116
Correlates of the discrepancy between objective and subjective cognitive functioning in non-demented patients with Parkinson’s disease 114
Comparing Essential Tremor with and without Soft Dystonic Signs and Tremor Combined with Dystonia: The TITAN Study 113
Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience 113
Memory Phenotypes In Early, De Novo Parkinson's Disease Patients with Mild Cognitive Impairment 112
A Novel Compound Heterozygous Mutation in Aprataxin Causes Slowly Progressive Ataxia without Oculomotor Apraxia 112
Correction to: Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 111
Brain Networks and Cognitive Impairment in Parkinson's Disease 111
Effects of safinamide on non-motor, cognitive, and behavioral symptoms in fluctuating Parkinson's disease patients: a prospective longitudinal study 111
Resting-State Functional MRI Approaches to Parkinsonisms and Related Dementia 110
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease 108
Spinocerebellar ataxia 27B: a frequent and slowly progressive autosomal-dominant cerebellar ataxia—experience from an Italian cohort 106
Motor, behavioural, and cognitive correlates of fatigue in early, de novo Parkinson disease patients 106
Resting-state brain networks in patients with Parkinson's disease and impulse control disorders 105
Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease 104
Validation of new diagnostic criteria for fatigue in patients with Parkinson disease 103
Intrinsic brain functional connectivity predicts treatment-related motor complications in early Parkinson’s disease patients 103
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 101
Correlates of psychological distress in epileptic patients during the COVID-19 outbreak 99
Multidisciplinary care use in neurodegenerative complex diseases: The example of progressive supranuclear palsy and advanced Parkinson's disease in real-life 97
Predictors of fatigue severity in early, de novo Parkinson disease patients: A 1-year longitudinal study 96
Sex-related pattern of intrinsic brain connectivity in drug-naïve Parkinson's disease patients 95
The psychological correlates of fatigue in Parkinson's disease: Contribution of maladaptive metacognitive beliefs 93
Kufor Rakeb syndrome without gaze palsy and pyramidal signs due to novel ATP13A2 mutations 92
Can we predict development of impulsive–compulsive behaviours in Parkinson’s disease? 88
Clinical correlates of “pure” essential tremor: the TITAN study 88
Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension 88
Flexible brain dynamics underpins complex behaviours as observed in Parkinson's disease 85
Supplementary motor area functional connectivity in “drug-naïve” Parkinson’s disease patients with fatigue 85
Fading of brain network fingerprint in Parkinson's disease predicts motor clinical impairment 85
Speech Rhythm Variation in Early-Stage Parkinson's Disease: A Study on Different Speaking Tasks 84
Subjective memory decline in Parkinson's disease patients with and without fatigue 84
SCAR32: Functional characterization and expansion of the clinical‐genetic spectrum 82
Structural MRI in Idiopathic Parkinson's Disease 82
Validation of the Italian version of the PSP Quality of Life questionnaire 81
HPDL Biallelic Variants in Cerebral Palsy and Childhood‐Onset Hereditary Spastic Paraplegia: Human and Zebrafish Insights 80
Correlates of Psychological Distress in Patients with Parkinson's Disease During the COVID-19 Outbreak 79
Functional Connectivity Signatures of Parkinson's Disease 78
Family History in Parkinson's Disease: A National Cross‐Sectional Study 76
The Italian tremor Network (TITAN): rationale, design and preliminary findings 75
Early classification of functional connectomes in Parkinson’s disease: a comparison of machine learning classifiers using multi-scale topological features 74
A Short Version of Carers' Quality of Life Questionnaire for Parkinsonism: Data from Progressive Supranuclear Palsy Network 73
Pain and fatigue in Parkinson's disease: advances in diagnosis and management 73
Increased glucosylsphingosine levels and Gaucher disease in GBA1-associated Parkinson's disease 72
Distinctive Handwriting Signs in Early Parkinson’s Disease 71
A Short Progressive Supranuclear Palsy Quality of Life Scale: Data from the PSP‐NET 71
Impulse control behaviors in Parkinson's disease: Drugs or disease? Contribution from imaging studies 69
Functional motor disorders associated with other neurological diseases: Beyond the boundaries of "organic" neurology 68
Molecular Imaging Markers to Track Huntington’s Disease Pathology 67
Functional motor phenotypes: to lump or to split? 67
Clinical trial eligibility in PSP: Population representativeness and potential criteria adjustment based on PSP-NET findings 66
Editorial: Non-motor Symptoms in Primary Motor Neurological Disorders: From Molecular Pathways to Clinical and Therapeutic Implications 65
Functional Connectomics and Disease Progression in Drug-Naïve Parkinson's Disease Patients 65
Characterising alexithymia in individuals with functional motor disorders: a cross-sectional analysis of the Italian Registry of Functional Motor Disorders 63
Analyzing Information Exchange in Parkinson’s Disease via Eigenvector Centrality: A Source-Level Magnetoencephalography Study 61
Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study 61
Levodopa-carbidopa intrajejunal infusion in Parkinson's disease: untangling the role of age 61
REM behavior disorder predicts motor progression and cognitive decline in Parkinson disease 60
Functional Changes of the Perigenual Part of the Anterior Cingulate Cortex after External Trigeminal Neurostimulation in Migraine Patients 57
Effects of GBA1 Variants in Patients With Parkinson's Disease and Levodopa–Carbidopa Intestinal Gel: A Nation‐Wide, Multicenter, Longitudinal, “Real‐World” Study. The EPIC Study 48
Psychometric properties and clinical correlates of the Frontal Behaviour Inventory in progressive supranuclear palsy: data from the PSP-NET 44
LC-MS/MS-Based Determination of Ambroxol in Human Plasma and Cerebrospinal Fluid: Validation and Applicability in a Phase II Study on GBA-Associated Parkinson’s Disease Patients 41
Gender Is the Main Predictor of Wearing‐Off and Dyskinesia in Levodopa‐Naïve Patients with Parkinson's Disease 38
The Complex Pathway of Conventional Investigations before the Diagnosis of Functional Motor Disorders 36
From mild cognitive impairment to normal cognition in Parkinson's disease: The role of brain network architecture 9
Exploring brain correlates of muscular activity and postural sway 4
Sex-related differences in striatal functional connectivity in early Parkinson’s disease 3
Totale 8.713
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022235 0 9 1 10 70 4 6 8 13 21 25 68
2022/2023483 43 8 6 23 53 19 2 13 292 13 5 6
2023/2024374 28 16 18 17 110 79 9 5 1 8 27 56
2024/20251.233 8 28 7 29 226 181 169 132 162 103 91 97
2025/20265.851 244 392 250 291 448 3.079 341 227 210 211 104 54
2026/2027110 49 61 0 0 0 0 0 0 0 0 0 0
Totale 8.713